Emergency room physician Dr. Ron Elfenbein dedicated himself to serving his community during the pandemic. In 2016, he founded an urgent care center in Maryland, which expanded rapidly when the virus hit. Anticipating the crisis, he stockpiled personal protective equipment (PPE) and testing supplies. His facilities became one of the busiest testing sites in the state, growing from one to eight locations and employing over 300 people at peak. Elfenbein donated PPE nationwide, distributed intubation boxes for free, volunteered extra ER shifts, tested nursing home residents at personal risk, and wrote a free e-book to ease public fears. He appeared frequently in media, advocating for early treatments like monoclonal antibodies, becoming Maryland’s largest outpatient provider of this therapy—surpassing major institutions like Johns Hopkins.
Elfenbein received citations from Maryland’s governor, state legislature, and medical society for his heroic efforts. Yet, in 2022, the federal government indicted him on healthcare fraud charges, alleging he submitted over $15 million in false claims by “upcoding” evaluation and management (E/M) visits during COVID. Prosecutors claimed he billed moderate-complexity Level 4 visits (codes 99214/99204) for patients coming to get tested for COVID, inflating reimbursements by about $50 per visit, despite relaxed pandemic guidelines encouraging provider evaluations alongside testing.
Elfenbein described the indictment as a nightmare, turning his life upside down without warning. He faced up to 50 years in prison, lost banking services, TSA PreCheck, firearm ownership, and school volunteering privileges. The ordeal devastated his family—his wife, a pediatric oncologist at Johns Hopkins, and their four children required therapy. Amid his father’s terminal illness, Elfenbein struggled with grief and fear of missing his children’s milestones.
The indictment was brought prior to reviewing any charts and followed on the heels of an interview Elfenbein did on Fox News where he berated Biden for pulling monoclonal antibodies as a treatment for COVID. At trial in 2023, the government focused on five patient charts out of over 100,000, arguing insufficient time spent, medical necessity lacking, and inaccurate documentation via templates. Elfenbein’s defense highlighted coding ambiguity under 2021 guidelines, where medical decision-making—not time—determined levels. COVID presented an “undiagnosed new problem with uncertain prognosis,” warranting Level 4, especially with dual testing (rapid and PCR). A professional coder testified his billing was 100% accurate, even under-coded in some cases. The government’s expert faltered, unfamiliar with pandemic-specific rules.
A jury convicted him on five counts, but Chief Judge James K. Bredar acquitted him post-trial in a rare 93-page ruling, stating insufficient evidence of falsity and criticizing the prosecution’s reliance on “common sense” over technical compliance. Bredar noted citizens cannot face criminal liability for reasonable interpretations of ambiguous regulations.
The Fourth Circuit reversed the acquittal in 2025, finding thin but sufficient evidence for a jury to convict, including alleged false documentation. However, it affirmed a new trial due to the case’s closeness. The Supreme Court declined review, leaving Elfenbein facing retrial amid mounting legal costs exceeding millions.
Elfenbein’s story exemplifies “lawfare”—weaponized prosecution against outspoken individuals. His advocacy for monoclonals clashed with vaccine prioritization, and his public criticism of federal mishandling may have drawn scrutiny. It underscores dangers in ambiguous billing rules, where reasonable compliance risks criminalization. As of late 2025, Elfenbein awaits retrial, hoping for dismissal. His case warns of justice system perils for those who serve boldly in crisis.
Please consider a donation to Dr. Elfenbein’s GoFundMe to assist with his legal bills.
